Europe — EMA
Zelboraf (Vemurafenib)
Zelboraf (Vemurafenib) is an oral prescription medication used for targeted cancer therapy. This targeted therapy works by blocking specific proteins to slow tu
Request sourcing
What is Vemurafenib?
Zelboraf (Vemurafenib) is an oral prescription medication used for targeted cancer therapy. This targeted therapy works by blocking specific proteins to slow tumor growth. It is prescribed under medical supervision for certain conditions. Always follow healthcare provider guidance when using this medication.
What is Vemurafenib used for?
Zelboraf is primarily used in the treatment of specific types of cancer, including melanoma. It is prescribed when cancer cells have a particular genetic mutation. Patients often ask, 'what is Zelboraf used for?' to understand its role in therapy. This medication is part of a broader approach to cancer management.
What are the side effects of Vemurafenib?
Zelboraf may cause side effects such as fatigue, joint pain, or nausea. Some patients experience skin reactions like rash or sensitivity to sunlight. Hair loss and changes in taste are also reported. These effects vary by individual and should be monitored by a healthcare professional.
What precautions apply to Vemurafenib?
Store Zelboraf at room temperature away from moisture and heat. Keep this medication out of reach of children and pets. Do not use if the packaging is damaged or expired. Always inform your healthcare provider about all medications and supplements you are taking before starting Zelboraf.
What does Vemurafenib interact with?
Zelboraf may interact with other medications, including certain antidepressants and blood thinners. Avoid grapefruit products as they can affect how the drug works. CYP3A4 inhibitors or inducers may alter Zelboraf levels in the body. Discuss all current medications with your doctor to avoid potential interactions.



